Improved pilot editing system efficiency with cis-action regulatory elements
The present invention is a synthetic nucleic acid composition comprising i) a sequence encoding a CRISPR-Cas protein, ii) a sequence encoding a reverse transcriptase, and iii) a sequence encoding a cis-acting regulatory element, and methods of use thereof. 本发明是一种合成核酸组合物及其使用方法,所述合成核酸组合物包含:i)编码CRISPR-...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention is a synthetic nucleic acid composition comprising i) a sequence encoding a CRISPR-Cas protein, ii) a sequence encoding a reverse transcriptase, and iii) a sequence encoding a cis-acting regulatory element, and methods of use thereof.
本发明是一种合成核酸组合物及其使用方法,所述合成核酸组合物包含:i)编码CRISPR-Cas蛋白的序列,ii)编码逆转录酶的序列,和iii)编码顺式作用调控元件的序列。 |
---|